News
05-29-2015, 06:02 AM
Biscayne Pharmaceuticals, Inc., today announced that data supporting the anti-cancer potential of its growth hormone-releasing hormone (GHRH) technology will be discussed in a poster presentation at the 2015 ASCO Annual Meeting.
More... (http://www.news-medical.net/news/20150528/Data-supporting-anti-cancer-potential-of-Biscaynee28099s-GHRH-antagonist-to-be-discussed-at-ASCO-Annual-Meeting.aspx)
More... (http://www.news-medical.net/news/20150528/Data-supporting-anti-cancer-potential-of-Biscaynee28099s-GHRH-antagonist-to-be-discussed-at-ASCO-Annual-Meeting.aspx)